chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient presented with large circumferential pericardial effusion with cardiac tamponade; Patient presented with large circumferential pericardial effusion with cardiac tamponade; shortness of breath and lightheadedness for the past few days; shortness of breath and lightheadedness for the past few days; nausea; intermittent fevers and chills/temperature reaching 102 Fahrenheit; intermittent fevers and chills; Vomiting; She Cannot lay backwards; This is a spontaneous report from a non-contactable other HCP. A 39-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 2 intramuscular administered in Arm Left on 10Jun2021 (age at vaccination: 39-years-old) (Batch/Lot Number: EW0181) as single dose for COVID-19 immunization. Medical history included systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA) from an unknown date and unknown if ongoing. Prior to vaccination, patient was not diagnosed with COVID-19. The patient's concomitant medications were not reported. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient previously took remicade and experienced allergy; bnt162b2, dose 1 intramuscular administered in Arm Left on 20May2021 (Batch/Lot Number: EW0185) for COVID-19 immunization. Age at vaccination was 39 years old. The patient experienced patient presented with large circumferential pericardial effusion with cardiac tamponade, shortness of breath and lightheadedness for the past few days, nausea, intermittent fevers and chills, vomiting, she cannot lay backwards on 15Jun2021 with outcome of recovering, reported as hospitalization, life threatening. Treatment received for the adverse event included Pericardiocentesis. Since the vaccination, patient has not been tested for COVID-19. Clinical course reported as follow: Patient presented with large circumferential pericardial effusion with cardiac tamponade, shortness of breath and lightheadedness for the past few days, that started after she got the second COVID-19 vaccine, Pfizer. She said nausea, vomiting, intermittent fevers and chills, and shortness of breath that have waxed and waned over the past 2 days but immediately got worse today. She could not lay backwards, her symptoms felt better leaning forwards. She was also had fevers and chills, temperature reaching 102 Fahrenheit. AE resulted in Doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care, Hospitalization, Life threatening illness (immediate risk of death from the event). The patient underwent lab tests and procedures which included body temperature: 102 Fahrenheit on 15Jun2021, Covid19 PCR (Nasal Swab): Negative on 15Jun2021.  No follow-up attempts are possible. No further information is expected.
I currently have lost my period. I contacted my doctor and was prescribed Provera. I am still dealing with this at this time.
heart palpitations and felt flush and over stimulated like I have had novocaine with epi at the dentist. Breathing was fast but that might have been panic. I don't know if it was an allergy or sensitivity and am concerned about getting my second dose on February 24.  2) Also, my injection site was red and sore for the first day but got progressively worse day 2-4 with a red raised hot area and pain that made it stiff to raise my arm. By day 5 it resolved.
pt developed symptoms after taking covid vax.  She has extreme fatigue, has SOB, loss of appetite, body aches, headache, lightheaded, dizziness, and vomiting.  Pt feels as if she is going to die.  She is in the woman's corrections facility.  She has had blood work and told she is loosing blood.  Her hemoglobin is 7 and she is anemic.  She is still waiting on more labs results.
Patient had COVID monovalent vaccine on 8/22/22. Patient then received COVID bivalent booster on 10/3/22. CDC recommends a 2 month interval between last vaccine. Patient received vaccine too early. Patient inquired about the bivalent vaccine during nurse visit. Patient notified of error. Patient aware to repeat bivalent booster in at least 8 weeks.
Day 1 Joint pain in hands, wrists, knees   my ribs hurt especially the right rib, heart rate pulsing sensation in the morning in the middle of my chest , left arm soreness at injection , light headed-floating Day 2 left calf throbbing, like electricity night ad morning continues both legs pins and needles, ligtning Day 7  both legs pins and needles, lightning   also felt like the flesh was being torn from my upper thigh on the right                chest pain, moody, joint stiffness and soreness Day 1-25  lack of sleep  only slept one night longer than 6 hours due to weird health issues listed above tried tylenol aand/or advil a few times  Day 15 lower lip burning ( i thought maybe poison ivy would happen but just a pain, then finger tips heated and tender             pulses in lower legs continue, left eye tender Day 25 Injection site pain came back left arm new tingling at he top of my head-scalp
This spontaneous report as received from a nurse refers to a patient with unknown age and gender. The patient's medical history was not reported. On 21-MAR-2014 the patient was vaccinated with an expired dose of PROQUAD (lot # H015638, expiration date: 23-FEB-2014) 0.5 ml, subcutaneous. Concomitant therapy was not reported. No adverse events were reported. Additional information is not expected.
Information has been received on 20-APR-2017 regarding a case in litigation from a lawyer and a female consumer of unknown age. The patient's concurrent conditions, medical history and concomitant medications were not reported. The patient was inoculated with ZOSTAVAX (lot number and expiration not reported) subcutaneous on or about 13-NOV-2012 by a physician, as recommended for routine adult health maintenance for the prevention of shingles. The vaccine did not prevent shingles as intended, but rather caused the patient to contract a persistent strain of herpes zoster. On or about 29-APR-2016, the patient was treated by a physician for a painful rash that was diagnosed as shingles. While shingles is an incurable condition, the patient has been prescribed VALTREX to manage her outbreaks. As a direct and proximate result of these malfunctions, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. Additional information has been requested.
Sharp chest pain, difficulty breathing and heart palpitations started in afternoon of 12/09. Started at around 1-3:30PM. Went to an urgent care for further testing and they performed a full EKG. That appeared normal. Blood pressure too was normal. They sent me to another ER for further testing. Arrived at ER evening of 12/09 and had full blood panel, testing of enzymes, d-diner and troponin levels tested. All was negative. Following morning on 12/10, pain persisted. Took self to ER. Doctor performed full chest X-ray and all showed no major issues. Completed a heart ultra sound, all showed no major issues. EKG was normal, however, depression line was deeper, which indicated Pericarditis, as well as described symptoms. Pericardium in Ultrasound showed swelling. Diagnosed with Pericarditis and was prescribed colchicine for treatment with NSAIDS. Followed up with a cardiologist on 12/16. Confirmed diagnosis of Pericarditis. Continuation of treatment for 3 months. Followed up with Bariatric doctor, has reason to believe that because there?s no underlying health issues that mRNA booster was cause for adverse reaction in pericarditis.
Since the receiving the second dose of the vaccine, I had numerous near-syncope episodes, starting the night of the second day of the receipt There were at least three serious episodes - two while attempting to urinate at night and one after attempting to work out. I had shortness of breath which still returns at times. Prior to the second dose, I exercised at the gym almost daily for 1 hours and in addition walked daily for at least 2 hours. Since the second dose, I am no longer able to exercise, and started to be able to walk more than a mile without feeling short of breath and like I was about to pass out only a week after its receipt. The most severe near syncope episode occurred a week after the receipt of my second dose. The day after that I experienced severe shortness of breath. I spent Sunday, a week after the second dose in bed with these symptoms. I am just now beginning to be able to go up the stairs without issues. Today is Sunday almost two weeks after the receipt of the second dose, and I experienced shortness of breath in the first 5 minutes of my walk. Then it got better, then it got bad again 30 minutes into it. This is not at all normal for me.
A week later I got "Corona arm," a raised, red, itching patch about 3" around.It lasted only about 24 hrs.
RespDepression Employee reported "50% airway obstruction after vaccination, self-medicated to address Sx, resolved after 48 hours. Did not seek medical evaluation." Narrative:
symptoms started the same day approximately around 6 pm.  I stated feeling bad, wasn't able to stand being up much longer and wanted to day down the soon as possible started having body aches, muscles soreness, chest discomfort, sore hands and feet, back pain, knee swelling, arm soreness with swelling and able to move injected arm, chills/shakes, extreme headaches, felt hot, with fever, my urine was dark and warmer then normal with no appetite. I just curled up in bed, and had a rough night of rest.
This spontaneous report as received from a pharmacist refers to a patient of unknown age and gender. Relevant medical history and concomitant medication were not provided. On 28-FEB-2014 the patient was vaccinated with GARDASIL. Lot number, dose, route and frequency were not provided. The vaccine was exposed to 56F for 10 days, an excursion that was found to be unsupported by in-house stability data. No adverse event was reported. Additional information has been requested.
Arm got progressively more sore after injection.  Sought medical care and needed PT to work on Range of Motion and Darvocet for pain.
Pain, tingling and numbness in L forearm and hand, especially thumb; this persisted til 4/28, and returned more mildly 4/29
Information has been received concerning a case litigation regarding a male minor child who starting in July of 1998 through November 1999 was inoculated with his infant vaccinations and through these vaccinations was subjected to high doses of mercury contained in the preservative Thimerosal. Immunization information was received and reported that the patient was vaccinated with the first, second, and third doses of hepatitis B virus vaccine rHBsAg on 7/21/98, 9/28/98, and 2/15/99. Other vaccinations included diphtheria toxoid (+) pertussis vaccine (+) tetanus toxoid received on 7/21/98, 9/28/98, 11/16/98, 11/19/99; poliovirus vaccine received on 9/30/99; and varicella virus vaccine live received on 9/30/99. It was also noted that the patient was diagnosed with Autistic Spectrum Disorder. It is alleged that the patient was poisoned by the cumulative doses of mercury in thimerosal and as a result now suffers and in the future will continue to suffer from the toxic neurological effects of mercury poisoning. Upon internal review, mercury poisoning, it's toxic neurological effects, and Autistic Spectrum Disorder were considered to be other important medical events. No further information is available. A copy of the patient's complete medical records is available upon request.
In the evening day of vaccine was given mom notice pt seemed to be dizzy and losing his balance. On 1/15/04 doctor's office seems fine no fever. No loss of balance. Ref to pediatric neurology.
This case was reported by a other health professional via sales rep and described the occurrence of adverse reaction in a female patient who received Seasonal Influenza vaccine. On an unknown date, the patient received Seasonal Influenza vaccine at an unknown dose. On an unknown date, an unknown time after receiving Seasonal Influenza vaccine, the patient experienced adverse reaction. On an unknown date, the outcome of the adverse reaction was unknown. It was unknown if the reporter considered the adverse reaction to be related to Seasonal Influenza vaccine. Additional details were provided as follows: The patient's age at vaccination was not reported. The details of the reaction was not reported. For tolerability after FLUARIX QUADRIVALENT, please see case US2016GSK166611.
patient received an expired dose / expiration date: 08/08/2021; This case was reported by a other health professional via call center representative and described the occurrence of expired vaccine used in a 11-year-old female patient who received DTPa (Reduced antigen) (Boostrix) (batch number X2XJ7, expiry date 8th August 2021) for prophylaxis.   On 9th August 2021, the patient received Boostrix. On 9th August 2021, unknown after receiving Boostrix, the patient experienced expired vaccine used. On an unknown date, the outcome of the expired vaccine used was unknown.  Additional details were provided as follows: The Medical assistant called to report that, the patient received an expired dose of Boostrix, which led to expired vaccine used. The reporter wanted to know if she had to revaccinate the patient or if the dose given was considered valid. The reporter did not consent to follow up. No further details were reported.
ADMINISTRATION OF EXPIRED VACCINE; This spontaneous report received from a consumer concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 205A21A, and expiry: 21-SEP-2021) dose was not reported, administered on 23-SEP-2021 for prophylactic vaccination. No concomitant medications were reported. On 23-SEP-2021, the patient experienced administration of expired vaccine. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of administration of expired vaccine was not reported. This report was non-serious. This case, from the same reporter is linked to 20210952662, 20210953012 and 20210952909.
Swelling of lips mild periorbital edema ha, body aches, nausea.
swelling  redness vesicles and some itching to right deltoid, right upper arm, right forearm, right wrist
Pt recvd 2 doses of Engerix-B & devel erythema @ site & rash on rt arm, ankle & tummy 24 hrs p/2nd dose; tx Caladryl;
About 8-24 hours after receiving 2nd dose: Vomiting, body aches, fever, migraine, fatigue, chills; 24-48 hours after 2nd dose: severe body aches, fatigue
Began to have swelling of face and eye that then traveled to right ear.  She had tightening of her throat.  Mother took her to ER.
Husband stated that wife had extreme shoulder pain where shot was given when she woke up Sat morning 10-4-08. Took MOTRIN helped some
Right sided face pain and touch sensitivity consisted with herpes zoster prodrome for which Acyclovir was started today.
reactive arthritis flare in right knee and left foot/2 weeks after second shot, reactive arthritis flare again same locations; reactive arthritis flare in right knee and left foot/2 weeks after second shot, reactive arthritis flare again same locations; This is a spontaneous report from a contactable consumer (patient). A 40-year-old male patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) on 11Mar2021 09:00 (Batch/Lot Number: EN6208) then the 2nd dose on 01Apr2021 (Batch/Lot Number: ER8733) both given via an unspecified route of administration administered  on arm left as SINGLE DOSE for COVID-19 immunization.  Medical history included arthritis reactive, attention deficit hyperactivity disorder (ADD) and elevated blood pressure. The patient also had allergies with nonsteroidal anti-inflammatory drug (NSAID) manifested as NSAID related bleeding. Concomitant medications included amfetamine aspartate, amfetamine sulfate, dexamfetamine saccharate, dexamfetamine sulfate (ADDERALL), metoprolol (METOPROLOL), rosuvastatin (ROSUVASTATIN) and methylprednisolone acetate (METHYLPREDNISOLONE) all taken for unspecified indications and therapy dates.  The patient had received his first dose of PFIZER-BIONTECH COVID-19 VACCINE on 11Mar2021 09:00. On 25Mar2021 06:00 (2 weeks after first shot), the patient had reactive arthritis flare in right knee and left foot. Then, the patient received the 2nd dose of PFIZER-BIONTECH COVID-19 VACCINE on 01Apr2021. On 15Apr2021 (2 weeks after second shot), the patient again reactive arthritis flare again same locations. The patient stated that this was uncommon in winter/spring season transition, but the timing of flares was strange. The patient requires doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care for the events and was treated with "MERRILY DOSEPAK". The patient had no COVID-19 prior vaccination no not tested for COVID-19 post vaccination. The patient was recovering from the events.
Onset of symptoms on 3/1/07: fever, sore throat, cough, and myalgia.  Respiratory failure on 3/6/07.  6/1/07 Received Death Certificate from epidemiologist which reveals COD asmultiorgan system failure and influenza B viral sepsis with contributing cause of staphyloccoccal secondary infection.  Medical records included w/death certificate indicate patient was transferred to higher level of care on 3/6, was intubated & in PICU w/pneumonia & ARDS.  Reportedly had been in good health until 3/1/07 when she developed sore throat, nasal congestion, rhinnorhea & low grade fever.  COntinued to worsen & developed myalgias, chest pain & nonproductive cough w/higher fever.  Seen by PCP on 3/5 & rapid strep was neg & dx was probable influenza.  Sent home & developed nausea, vomiting & diarrhea as well as petechial rash over abdomen.  Taken to outlying ER on 3/6 & found to be in respiratory failure, intubated & transferred to higher level of care.  Respiratory status declined further & was placed on oscillator & ECMO.  Peds ID consult done.  Consult states had HPV vax at PCP on 3/2 & no other recent vaccines. 6/1/07 Received fax medical & vaccine records from CDC who had contacted provider.  Reveals that on 1/2/07, patient received TDaP & HPV.  On 3/2/07 received HPV #2.  VAERS database updated w/same.  On day of vax patient also dx w/right CTS, migraine HA, scoliosis.  She was referred to Neuro & PT for the CTS & HA.
This report refers to unspecified patients enrolled in a not blinded other studies on line at clinicaltrials.gov in which patients under the age of 50 years old received ZOSTAVAX. She reported that the study was started in July 2011 and completed in April 2012 and was sponsored by University. No adverse effect reported. Additional information has been requested.
12 People were vaccinated with the Moderna Covid 19 vaccine past its beyond use by date; 12 People were vaccinated with the Moderna Covid 19 vaccine past its beyond use by date; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (12 People were vaccinated with the Moderna Covid 19 vaccine past its beyond use by date) and PRODUCT STORAGE ERROR (12 People were vaccinated with the Moderna Covid 19 vaccine past its beyond use by date) in a 55-year-old patient of an unknown gender who received mRNA-1273 (Spikevax) (batch no. 058A22-2A) for COVID-19 prophylaxis.     No Medical History information was reported.    In July 2022, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. In July 2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (12 People were vaccinated with the Moderna Covid 19 vaccine past its beyond use by date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (12 People were vaccinated with the Moderna Covid 19 vaccine past its beyond use by date). At the time of the report, EXPIRED PRODUCT ADMINISTERED (12 People were vaccinated with the Moderna Covid 19 vaccine past its beyond use by date) and PRODUCT STORAGE ERROR (12 People were vaccinated with the Moderna Covid 19 vaccine past its beyond use by date) outcome was unknown.        For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was provided.  Number of doses, vials reported  were 3 vials and 12 doses.  The dates of administration and number patients were reported as on 16-Jul-2022 to 3 patients, on 23-Jul-2022 to 5 patients, on 24-Jul-2022 to 4 patients.  All the vials were moved to fridge on the same day on 13-Jun-2022.  The vial did not undergo any temperature excursions.  No treatment medication was provided.  This case contains information for the 9th of the 12 patients who received the vaccine on Jul-2022 as described by the reporter.   Most recent FOLLOW-UP information incorporated above includes: On 27-Jul-2022: Follow up received and Narrative updated.
This spontaneous report as received from a nurse refers to an unspecified number of unspecified patients. The patients' medical history, concurrent condition and concomitant therapy were not reported. On unspecified dates, an unspecified number of unspecified patients received a dose of improperly stored PROQUAD (Lot# reported as N002916, expiration date 24-JUL-2018 or Lot# N013268, expiration date 25-OCT-2018) (dose, frequency and route were not reported). The lot numbers and expiration dates of the sterile diluent (manufacturer unknown) used for reconstitution was unknown by reporter (dose, frequency and route were not reported). The sterile diluents did not undergo any temperature excursion. The vaccine was exposed to temperature excursion of 6 F to 14 F for 4 hours and the data logger was involved. There was no previous temperature excursion. No adverse effects reported. This is one of several reports received from the same reporter.; Sender's Comments: US-009507513-1708USA000603:
This spontaneous report as received from a medical assistant refers to a multiple unspecified patients of unknown age and gender. The patients' concurrent conditions, medical history and concomitant therapies were not reported. On an unknown date, the patients received improperly stored (temperature: 34 degrees Fahrenheit and 51 degrees Fahrenheit for 14 hours; no previous excursion was reported) doses of VAQTA lot # L023936 and expiration date: 15-MAR-2017 (dose and route of administration were not reported). No adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested.
Reynaud's disease; Swollen toes; Numb toes; A spontaneous report was received from a consumer concerning herself, a 40-year old female patient, who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced  swollen toes, numb toes and diagnosed with Reynaud's disease.  The patient's medical history was not provided. Concomitant medication use was not provided by reporter.   ON 30-JAN-2021, prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 (Lot number 028L20A) for COVID-19 infection prophylaxis.   On 01-FEB-2021, the day after the dose of the Moderna vaccine, the patient experienced swollen toes, numb toes and was diagnosed with Reynaud's disease.  Treatment details included blood pressure medication.   Action taken with mRNA-1273 in response to the events was unknown.   The outcome of the events, swollen toes, numb toes and diagnosed with Reynaud's disease was considered to be not resolved at the time of this report.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of these events, a causal relationship cannot be excluded.
Patient became blotchy and tachypnic after vaccines. Provider perceived her to be dusky and not aerating well.